Faculty Opinions recommendation of Efficacy and safety of ETC-1002, a novel investigational low-density lipoprotein-cholesterol-lowering therapy for the treatment of patients with hypercholesterolemia and type 2 diabetes mellitus.
2014 ◽
Vol 34
(3)
◽
pp. 676-683
◽
2016 ◽
Vol 111
◽
pp. 66-73
◽
2015 ◽
Vol 13
(2)
◽
pp. 84-90
◽
2002 ◽
Vol 89
(7)
◽
pp. 825-829
◽
2013 ◽
Vol 52
(21)
◽
pp. 2409-2415
◽
2013 ◽
Vol 21
(7)
◽
pp. 855-865
◽